| 廖音,崔向丽,甄健存,王文凤,李丹丹,陈宁,陈政凯,夏豆豆,颜冰.北京22家医院2型糖尿病合并ASCVD高风险人群降糖药应用情况分析[J].中国药事,2023,(1):96-101 |
| 北京22家医院2型糖尿病合并ASCVD高风险人群降糖药应用情况分析 |
| Analysis on the Use of Hypoglycemic Drug in T2DM with High ASCVD Risk in 22 Hospitals in Beijing |
| |
| DOI：10.16153/j.1002-7777.2023.01.011 |
| 中文关键词: 降糖药 使用率 动脉粥样硬化性心血管疾病风险 药品集中采购 处方合格率 |
| 英文关键词: hypoglycemic drugs application rate ASCVD risk centralized procurement of drugs qualifi ed rate of prescription |
| 基金项目: |
|
| 摘要点击次数: 958 |
| 全文下载次数: 302 |
| 中文摘要: |
| 目的：分析近年合并动脉粥样硬化性心血管疾病(ASCVD)高风险的2型糖尿病患者降糖药使用率、金额及其合理性，发现新型降糖药使用中的处方问题，促进临床合理用药。方法：抽取2016- 2020年北京市22家市属医院ASCVD高风险的2型糖尿病患者的门诊降糖药处方，对不合理处方、降糖药金额、药物使用率变化进行分析。结果：在2016-2020年，各类新型降糖药使用率呈增加趋势， 而胰岛素促泌剂、噻唑烷二酮类、预混胰岛素用量呈下降趋势。降糖药处方平均金额2019年最高， 为(392.52±364.04)元，2020年降至(251.82±293.35)元，降幅达35.85%。2017年后处方合格率从 89.26%上升至97%以上。结论：新型降糖药越来越广泛应用于心血管高危糖尿病患者，其用药合理性及经济性需要加以监管。在此方面，北京市医院管理中心推进的处方前置审核、国家药品集中采购政策， 对提高降糖药处方合格率、降低药品次均费用有非常积极的作用，有助于保障北京糖尿病患者的用药水平及用药合理性，有助于实现医疗卫生体制改革公益性目标。 |
| 英文摘要: |
| Objective: To analyze the utilization rate, amount and rationality of the hypoglycemic drugsin type 2 diabetes (T2DM) with high atherosclerotic cardiovascular (ASCVD) risk in recent years, to explored the prescription problems in the use of new hypoglycemic drugs and promote rational clinical of drug use. Methods: The review data of outpatients hypoglycemic drugs prescriptions in T2DM with high ASCVD were selected from 2016 to 2020 in 22 hospitals in Beijing, from which irrational prescriptions and amount of hypoglycemic drugs and the utilization ratechanges ofhypoglycemic drugs were analyzed. Results: In 2016-2020, the use rate of all kinds of new-type hypoglycemic drugs showed an increasing trend, which insulin secretagogues, thiazolidinediones and premixed insulin were on the decline. The average prescription amount of hypoglycemic drugs was the highest in 2019, which was (392.52±364.04) yuan per capita, and fell to (251.82±293.35) in 2020, a decrease of 35.85%. The rational rates of prescription rose from 89.26% to over 97% after 2017. Conclusion: New-type hypoglycemic drugs were increasingly widely used in high ASCVD risk diabetes patients, the rationality and economy of drug use need to be monitored.In this regard, the prescription pre-examination and the national centralized drug procurement policy promoted by Beijing Hospitals Authority play a very positive role in increasing the rational rates of hypoglycemic drugsprescription and effectively reducing the average drug expenses, which promoted the level and rationality of drug use for diabetic patients in Beijing, and accomplished the public welfare goal of medical and health system reform. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|